Anti-OTOG/ DFNB18B/ MLEMP functional antibody

Anti-OTOG/ DFNB18B/ MLEMP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OTOG/OTOG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1161-Ab-1/ GM-Tg-hg-SE1161-Ab-2Anti-Human OTOG monoclonal antibodyHuman
GM-Tg-rg-SE1161-Ab-1/ GM-Tg-rg-SE1161-Ab-2Anti-Rat OTOG monoclonal antibodyRat
GM-Tg-mg-SE1161-Ab-1/ GM-Tg-mg-SE1161-Ab-2Anti-Mouse OTOG monoclonal antibodyMouse
GM-Tg-cynog-SE1161-Ab-1/ GM-Tg-cynog-SE1161-Ab-2Anti-Cynomolgus/ Rhesus macaque OTOG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1161-Ab-1/ GM-Tg-felg-SE1161-Ab-2Anti-Feline OTOG monoclonal antibodyFeline
GM-Tg-cang-SE1161-Ab-1/ GM-Tg-cang-SE1161-Ab-2Anti-Canine OTOG monoclonal antibodyCanine
GM-Tg-bovg-SE1161-Ab-1/ GM-Tg-bovg-SE1161-Ab-2Anti-Bovine OTOG monoclonal antibodyBovine
GM-Tg-equg-SE1161-Ab-1/ GM-Tg-equg-SE1161-Ab-2Anti-Equine OTOG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1161-Ab-1/ GM-Tg-hg-SE1161-Ab-2; GM-Tg-rg-SE1161-Ab-1/ GM-Tg-rg-SE1161-Ab-2;
GM-Tg-mg-SE1161-Ab-1/ GM-Tg-mg-SE1161-Ab-2; GM-Tg-cynog-SE1161-Ab-1/ GM-Tg-cynog-SE1161-Ab-2;
GM-Tg-felg-SE1161-Ab-1/ GM-Tg-felg-SE1161-Ab-2; GM-Tg-cang-SE1161-Ab-1/ GM-Tg-cang-SE1161-Ab-2;
GM-Tg-bovg-SE1161-Ab-1/ GM-Tg-bovg-SE1161-Ab-2; GM-Tg-equg-SE1161-Ab-1/ GM-Tg-equg-SE1161-Ab-2
Products NameAnti-OTOG monoclonal antibody
Formatmab
Target NameOTOG
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OTOG benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1161-Ag-1Recombinant multi-species OTOG/ DFNB18B/ MLEMP protein


    Target information

    Target IDGM-SE1161
    Target NameOTOG
    Gene ID340990,18419,292918,100424357,485403,101096350,506301,100071797
    Gene Symbol and Synonyms4932420K09,DFNB18B,MLEMP,OTGN,OTOG,twt
    Uniprot AccessionQ6ZRI0
    Uniprot Entry NameOTOG_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188162
    Target ClassificationN/A

    The target: OTOG, gene name: OTOG, also named as DFNB18B, MLEMP, OTGN. The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.